Tag Archives: transhumanism


U.S. Transhumanist Party Discussion Panel on Life Extension – February 18, 2017

No comments yet

Categories: Politics, Science, Transhumanism, Tags: , , , , , , , , , , , , , , , , , , ,


The New Renaissance Hat

Listen to and download the audio recording of this panel discussion at http://rationalargumentator.com/USTP_Life_Extension_Panel.mp3 (right-click to download).

For its second expert panel, the U.S. Transhumanist Party invited Bill Andrews, Aubrey de Grey, Ira Pastor, and Ilia Stambler to discuss life extension and the quest to reverse biological aging through science and technology.

This two-hour panel discussion, moderated by Chairman Gennady Stolyarov II, took place on Saturday, February 18, 2017, at 10 a.m. U.S. Pacific Time. In this interactive venue, many opportunities for fresh discourse arose on the possibility of achieving dramatically greater longevity within our lifetimes. The substance of the discussion begins at 4:25 in the recording.

Questions the panelists considered include the following:

(i) How would you characterize the current state of efforts to reverse senescence / lengthen human lifespans?
(ii) How does progress in the areas of research you have delved into compare to your expectations approximately 10 to 15 years ago?
(iii) What are the most significant challenges and obstacles that you perceive to exist in the way of achieving serious reversal of biological aging?
(iv) What key technologies and methods of delivering treatments to patients would need to be developed in order for longevity escape velocity to be affordably achieved society-wide?
(v) What political reforms and societal / attitudinal changes would you advocate to accelerate the arrival of effective treatments to reverse biological aging and lengthen lifespans?
(vi) Are you concerned about any current political trends and how they might affect the progress of research into combating biological aging?
(vii) What can laypersons who are sympathetic to your goals do in order to hasten their realization? How can the effort to defeat aging become as popular and widely supported as efforts to defeat cancer and ALS are today?
(viii) What lessons can the history of anti-aging research offer to those who seek to advocate and help achieve effective scientific breakthroughs in this area in the coming years and decades?

Become a member of the U.S. Transhumanist Party for free. Apply here.


Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy” – Paper by Louise S. Hornstrup, Ruth Frikke-Schmidt, Børge G. Nordestgaard and Anne Tybjærg-Hansen. Arteriosclerosis, Thrombosis, and Vascular Biology. 2013;33:1441-1447, Originally published May 15, 2013.

Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy” – Paper by Ilia Stambler. Aging and Disease.



Dr. Bill Andrews is the President and CEO of Sierra Sciences – http://www.sierrasci.com/. As a scientist, athlete, and executive, he continually pushes the envelope and challenges convention. In his 35-year biotech career, he has focused the last 23 years on finding ways to extend the human lifespan and healthspan through telomere maintenance. As one of the principal discoverers of both the RNA and protein components of human telomerase, Dr. Andrews was awarded 2nd place as “National Inventor of the Year” in 1997.

Dr. Aubrey de Grey is the biomedical gerontologist who researched the idea for and founded SENS Research Foundation – http://www.sens.org/. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985 and 2000, respectively. Dr. de Grey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.

Ira Pastor has 30 years of experience across multiple sectors of the pharmaceutical industry, including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail. He is the CEO of BioQuark, Inc. – http://www.bioquark.com/ – and Executive Chairman of ReAnima Advanced Biosciences – https://reanima.tech/.

Dr. Ilia Stambler is a researcher at Bar Ilan University, Israel. His research focuses on the historical and social implications of aging and life-extension research. He is the author of A History of Life-extensionism in the Twentieth Century – www.longevityhistory.com. He is actively involved in advocacy for aging and longevity research – www.longevityforall.org.


U.S. Transhumanist Party Discussion Panel on Aritificial Intelligence – January 8, 2017

No comments yet

Categories: Politics, Technology, Transhumanism, Tags: , , , , , , , , , , , , , , ,

The New Renaissance Hat

The U.S. Transhumanist Party’s first expert discussion panel, hosted in conjunction with the Nevada Transhumanist Party, asked panelists to consider emerging developments in artificial intelligence.

The panel took place on Sunday, January 8, 2017, at 10 a.m. U.S. Pacific Time.

This panel was moderated by Gennady Stolyarov II, Chairman of the U.S. Transhumanist Party and Chief Executive of the Nevada Transhumanist Party. Key questions addressed include the following:

(i) What do you think will be realistic, practical applications of artificial intelligence toward improving human lives during the next 5 years?
(ii) Are you genuinely concerned about existential risk stemming from AI, or do you think those concerns are exaggerated / overhyped (or do you have some intermediate position on these issues)?
(iii) On the other hand, do you perceive significant tendencies in contemporary culture to overhype the positive / functional capabilities of AI?
(iv) How can individuals, particularly laypersons, become better at distinguishing between genuine scientific and technological advances in AI and hype / fear-mongering?
(v) What is your techno-optimistic vision for how AI can help improve the future of human (and transhuman) beings?
(vi) What are your thoughts regarding prognostications of an AI-caused technological Singularity? Are they realistic?


Zak Field is an international speaker, consultant, games designer, and entrepreneur based in Norwich, UK. A rising thought leader in Mixed Realities (VR/AR), Zak speaks and consults on Mixed Realities-related topics like gamification, Virtual Reality (VR), Augmented Reality (AR), Robotics, Artificial Intelligences (AIs), and the Internet of Things (IoT).

In 2015, Zak partnered with Futurist Miss Metaverse as co-founder of BodAi, a robotics and AI company developing Bods, lifelike humanoid robot companions made accessible through a unique system that accommodates practical 21st-Century business and lifestyle needs.

David J. Kelley is the CTO for the tech venture capital firm Tracy Hall LLC, focused on companies that contribute to high-density sustainable community technologies, as well as the principal scientist with Artificial General Intelligence Inc. David also volunteers as the Chairman of the Transhuman National Committee board. David’s career has been built on technology trends and bleeding each research primarily around the capitalization of product engineering where those new products can be brought to market and made profitable. David’s work on Artificial Intelligence in particular – the ICOM research project with AGI Inc. – is focused on emotion-based systems that are designed to work around human constraints and help remove the ‘human’ element from the design of AI systems, including military applications for advanced self-aware cognitive systems that do not need human interaction.

Hiroyuki Toyama is a Japanese doctoral student at the Department of Psychology in University of Jyväskylä, Finland. His doctoral study has focused on emotional intelligence (EI) in the context of personality and health psychology. In particular, he has attempted to shed light on the way in which trait EI is related to subjective well-being and physiological health. He has a great interest in the future development of artificial EI on the basis of contemporary theory of EI.

Mark Waser is Chief Technology Officer of the Digital Wisdom Institute and D161T4L W15D0M Inc., organizations devoted to the ethical implementation of advanced technologies for the benefit of all. He has been publishing data science research since 1983 and developing commercial AI software since 1984, including an expert system shell and builder for Citicorp, a neural network to evaluate thallium cardiac images for Air Force pilots and, recently, mobile front-ends for cloud-based AI and data science. He is particularly interested in safe ethical architectures and motivational systems for intelligent machines (including humans). As an AI ethicist, he has presented at numerous conferences and published articles in international journals. His current projects can be found at the Digital Wisdom website – http://wisdom.digital/

Demian Zivkovic is CEO+Structure of Ascendance Biomedical, president of the Institute of Exponential Sciences, as well as a scholar of several scientific disciplines. He has been interested in science, particularly neuropsychology, astronomy, and biology from a very young age. His greatest passions are cognitive augmentation and life extension, two endeavors he remains deeply committed to, to this day. He is also very interested in applications of augmented reality and hyperreality, which he believes have incredible potential for improving our lives.

He is a strong believer in interdisciplinarity as a paradigm for understanding the world. His studies span artificial intelligence, innovation science, and business, which he has studied at the University of Utrecht. He also has a background in psychology, which he has previously studied at the Saxion University of Applied Sciences. Demian has co-founded Ascendance Biomedical, a Singapore-based company focused on cutting edge biomedical services. Demian believes that raising capital and investing in technology and education is the best route to facilitate societal change. As a staunch proponent of LGBT rights and postgenderism, Demian believes advanced technologies can eventually provide a definite solution for sex/gender-related issues in society.


A Transhumanist Opinion on Privacy – Article by Ryan Starr

No comments yet

Categories: Culture, Politics, Transhumanism, Tags: , , , , , , , , , , , ,

The New Renaissance HatRyan Starr


Privacy is a favorite topic of mine. Maintaining individual privacy is a crucial element in free society. Yet there are many who want to invade it for personal or political gain. As our digital fingerprint becomes a part of our notion of self, how do we maintain our personal privacy on an inherently impersonal network of data? Where do we draw that line on what is private, and how do we enforce it? These are questions that are difficult to answer when looking at a short-term perspective. However, if we look further into the probable future, we can create a plan that helps protect the privacy of citizens today and for generations to come. By taking into account the almost certain physical merger of human biology and technology, the answer becomes clear. Our electronic data should be treated as part of our bodily autonomy.

The explosive success of social media has shown that we already view ourselves as partly digital entities. Where we go, what we eat, and who we are with is proudly displayed in cyberspace for eternity. But beyond that we store unique data about ourselves “securely” on the internet. Bank accounts, tax returns, even medical information are filed away on a server somewhere and specifically identified as us. It’s no longer solely what we chose to let people see. We are physical and digital beings, and it is time we view these two sides as one before we take the next step into enhanced humanity.

Subdermal storage of electronic data is here, and its storage capabilities will expand rapidly. Soon we will be able to store a lot more than just access codes for our doors. It is hard to speculate exactly what people will chose to keep stored this way, and there may even come a time when what we see and hear is automatically stored this way. But before we go too far into what will be stored, we must understand how this information is accessed in present time. These implants are currently based in NFC technology. Near-Field Communication is a method of storing and transmitting data wirelessly within a very short distance. Yes, “wireless” is the key word. It means that if I can connect my NFC tag to my smart phone by just waiving my hand close to it (usually within an inch or so), then technically someone else can, too. While current antenna limitations and the discreetness of where a person’s tag is implanted create a highly secure method of storage, advances in technology will eventually make it easier to access the individual. This is why it is urgent we develop a streamlined policy for privacy.

The current Transhumanist position is that personally collected intellectual property, whether stored digitally or organically, is the property of the individual. As such, it should be protected from unauthorized search and download. The current platform also states that each individual has the freedom to enhance their own body as they like so long as it doesn’t negatively impact others. However, it does not specify what qualifies as a negative impact or how to prevent it. Morphological freedom is a double-edged sword. A person can a person enhance their ability to access information on themselves, but they can also use it to access others. It is entirely feasible enhancements will be created that allow a person to hack another. And collecting personal data isn’t the only risk with that. What if the hacking victim has an artificial heart or an implanted insulin pump? The hacker could potentially access the code the medical device is operating with and change or delete it, ultimately leading to death. Another scenario might be hacking into someone’s enhanced sensory abilities. Much like in the novel Ender’s Game, a person can access another to see what they see. This ability can be abused countless ways ranging from government surveillance to sexual voyeurism. While this is still firmly within the realm of science fiction, a transhuman society will need to create laws to protect against these person-to-person invasions of privacy.

Now let’s consider mass data collection. Proximity beacons could easily and cheaply be scattered across stores and cities to function as passive collection points much like overhead cameras are today. Retail stands to gain significantly from this technology, especially if they are allowed access to intimate knowledge about customers. Government intelligence gathering also stands to benefit from this capability. Levels of adrenaline, dopamine, and oxytocin stored for personal health analysis could be taken and paired with location data to put together an invasive picture of how people are feeling in a certain situation. Far more can be learned and exploited when discreetly collected biodata is merged with publicly observable activity.

In my mind, these are concerns that should be addressed sooner than later. If we take the appropriate steps to preserve personal privacy in all domains, we can make a positive impact that will last into the 22nd century.
Ryan Starr is the leader of the Transhumanist Party of Colorado. This article was originally published on his blog, and has been republished here with his permission.


Towards a Greater Knowledge of Mitochondrial DNA Damage in Aging – Article by Reason

No comments yet

Categories: Science, Transhumanism, Tags: , , , , , , , , , , , , , ,

The New Renaissance HatReason

Today I’ll point out a very readable scientific commentary on mutations in mitochondrial DNA (mtDNA) and the importance of understanding how these mutations spread within cells. This is a topic of some interest within the field of aging research, as mitochondrial damage and loss of function is very clearly important in the aging process. Mitochondria are, among many other things, the power plants of the cell. They are the evolved descendants of symbiotic bacteria, now fully integrated into our biology, and their primary function is to produce chemical energy store molecules, adenosine triphosphate (ATP), that are used to power cellular operations. Hundreds of mitochondria swarm in every cell, destroyed by quality control processes when damaged, and dividing to make up the numbers. They also tend to promiscuously swap component parts among one another, and sometimes fuse together.

Being the descendants of bacteria, mitochondria have their own DNA, distinct from the nuclear DNA that resides in the cell nucleus. This is a tiny remnant of the original, but a very important remnant, as it encodes a number of proteins that are necessary for the correct operation of the primary method of generating ATP. DNA in cells is constantly damaged by haphazard chemical reactions, and equally it is constantly repaired by a range of very efficient mechanisms. Unfortunately mitochondrial DNA isn’t as robustly defended as nuclear DNA. Equally unfortunately, some forms of mutation, such as deletions, seem able to rapidly spread throughout the mitochondrial population of a single cell, even as they make mitochondria malfunction. This means that over time a growing number of cells become overtaken by malfunctioning mitochondria and fall into a state of dysfunction in which they pollute surrounding tissues with reactive molecules. This can, for example, increase the level of oxidized lipids present in the bloodstream, which speeds up the development of atherosclerosis, a leading cause of death at the present time.

The question of how exactly some specific mutations overtake a mitochondrial population so rapidly is still an open one. There is no shortage of sensible theories, for example that it allows mitochondria to replicate more rapidly, or gives them some greater resistance to the processes of quality control that normally cull older, damaged mitochondria. The definitive proof for any one theory has yet to be established, however. In one sense it doesn’t actually matter all that much: there are ways to address this problem through medical technology that don’t require any understanding of how the damage spreads. The SENS Research Foundation, for example, advocates the path of copying mitochondrial genes into the cell nucleus, a gene therapy known as allotopic expression. For so long as the backup genes are generating proteins, and those proteins make it back to the mitochondria, the state of the DNA inside mitochondria doesn’t matter all that much. Everything should still work, and the present contribution of mitochondrial DNA damage to aging and age-related disease would be eliminated. At the present time there are thirteen genes to copy, a couple of which are in commercial development for therapies unrelated to aging, another couple were just this year demonstrated in the lab, and the rest are yet to be done.

Still, the commentary linked below is most interesting if you’d like to know more about the questions surrounding the issue of mitochondrial DNA damage and how it spreads. This is, as noted, a core issue in the aging process. The authors report on recent research on deletion mutations that might sway the debate on how these mutations overtake mitochondrial populations so effectively.

Expanding Our Understanding of mtDNA Deletions

A challenge of mtDNA genetics is the multi-copy nature of the mitochondrial genome in individual cells, such that both normal and mutant mtDNA molecules, including selfish genomes with no advantage for cellular fitness, coexist in a state known as “heteroplasmy.” mtDNA deletions are functionally recessive; high levels of heteroplasmy (more than 60%) are required before a biochemical phenotype appears. In human tissues, we also see a mosaic of cells with respiratory chain deficiency related to different levels of mtDNA deletion. Interestingly, cells with high levels of mtDNA deletions in muscle biopsies show evidence of mitochondrial proliferation, a compensatory mechanism likely triggered by mitochondrial dysfunction. In such circumstances, deleted mtDNA molecules in a given cell will have originated clonally from a single mutant genome. This process is therefore termed “clonal expansion.”

The accumulation of high levels of mtDNA deletions is challenging to explain, especially given that mitophagy should provide quality control to eliminate dysfunctional mitochondria. Studies in human tissues do not allow experimental manipulation, but large-scale mtDNA deletion models in C. elegans have proved to be helpful, showing some conserved characteristics that match the situation in humans, as well as some divergences. Researchers have used a C. elegans strain with a heteroplasmic mtDNA deletion to demonstrate the importance of the mitochondrial unfolded protein response (UPRmt) in allowing clonal expansion of mutant mtDNAs to high heteroplasmy levels. They demonstrate that wild-type mtDNA copy number is tightly regulated, and that the mutant mtDNA molecules hijack endogenous pathways to drive their own replication.

The data suggests that the expansion of mtDNA deletions involves nuclear signaling to upregulate the UPRmt and increase total mtDNA copy number. The nature of the mito-nuclear signal in this C. elegans model may have been the transcription factor ATFS-1 (activating transcription factor associated with stress-1), which fails to be imported by depolarized mitochondria, mediates UPRmt activation by mtDNA deletions. A long-standing hypothesis proposes that deleted mtDNA molecules clonally expand because they replicate more rapidly due to their smaller size. To address this question, researchers examined the behavior of a second, much smaller mtDNA deletion molecule. They found no evidence for a replicative advantage of the smaller genome, and clonal expansion to similar levels as the larger deletion. In human skeletal muscle, mtDNA deletions of different sizes also undergo clonal expansion to the same degree. Furthermore, point mutations that do not change the size of the total mtDNA molecule also successfully expand to deleterious levels, indicating that clonal expansion is not driven by genome size. Thus, similar mechanisms may be operating across organisms. In the worm, this involves mito-nuclear signaling and activation of the UPRmt.

There is some debate over interpretation of results. One paper indicates that UPRmt allows the mutant mtDNA molecules to accumulate by reducing mitophagy. Another demonstrates that the UPRmt induces mitochondrial biogenesis and promotes organelle dynamics (fission and fusion). Both papers show that by downregulating the UPRmt response, mtDNA deletion levels fall, which may allow a therapeutic approach in humans. Could there be a similar mechanism in humans, especially since some features detected in C. elegans are also present in human tissues, including the increase in mitochondrial biogenesis and the lack of relationship between mitochondrial genome size and expansion? It is likely that there will be a similar mechanism to preserve deletions since, as in the worm, deletions persist and accumulate in human tissues, despite an active autophagic quality-control process. Although the UPRmt has not been characterized in humans as it has in the worm, and no equivalent protein to ATFS-1 has been identified in mammals, proteins such as CHOP, HSP-60, ClpP, and mtHSP70 appear to serve similar functions in mammals as those in C. elegans and suggest that a similar mechanism may be present.

Reason is the founder of The Longevity Meme (now Fight Aging!). He saw the need for The Longevity Meme in late 2000, after spending a number of years searching for the most useful contribution he could make to the future of healthy life extension. When not advancing the Longevity Meme or Fight Aging!, Reason works as a technologist in a variety of industries.
This work is reproduced here in accord with a Creative Commons Attribution license. It was originally published on FightAging.org.


Crowdfunding Longevity Science: An Interview with Keith Comito of Lifespan.io – Article by Reason

No comments yet

Categories: Science, Transhumanism, Tags: , , , , , , , , , , , , ,

The New Renaissance HatReason

Keith Comito leads the volunteers of the non-profit Life Extension Advocacy Foundation (LEAF) and the crowdfunding initiative Lifespan.io, a site I’m sure you’ve seen at least in passing by now. The LEAF crew have put in a lot of effort to help make fundraisers for rejuvenation research projects a success both last year and this year. Two such crowdfunding campaigns are running right now, firstly senolytic drug research at the Major Mouse Testing Program with just a few days left to go, and in its stretch goals, and secondly the recently launched drug discovery for ALT cancers at the SENS Research Foundation. Both tie in to the SENS portfolio of research programs aimed at effective treatment of aging and all age-related conditions. These are large projects when taken as a whole, but the way forward in this as in all things is to pick out smaller, achievable goals, and set out to get them done. Then repeat as necessary.

I recently had the chance to ask Keith Comito a few questions about Lifespan.io, the state of funding for the interesting end of longevity science, and what he envisages for the years ahead. This is an interesting, revolutionary time for the life sciences, in which progress in biotechnology has made early stage research very cheap. A great deal can be accomplished at the cutting edge of medical science given access to an established lab, administrators who can break out small initiatives from the larger goals, smart young researchers, and a few tens of thousands of dollars. It is an age in which we can all help to advance the research we care about, by collaborating and donating, and it has never been easier to just reach out and talk to the scientists involved. If you haven’t taken a look at Lifespan.io and donated to one of the projects there, then you really should. This is a way to move the needle on aging research, and advance that much closer to effective treatments for the causes of aging.


What is the Lifespan.io story in brief? What was the spur that made you come together and decide to do your part in the fight against aging?

Lifespan.io began to take shape at the tail end of 2012, as a result of a loose discussion group based in New York which consisted of citizen scientists such as myself and Dr. Oliver Medvedik, supporters of SENS, as well as a few healthcare practitioners. We began having monthly meetings to discuss what could be done to accelerate longevity research (usually in oddball locations like salad bars or subterranean Japanese restaurants befitting our motley crew) and eventually hit upon the idea of crowdfunding. What drew us to this idea was that it was something tangible: a concrete way to move the needle on important research not only through funds, but through raised awareness. It is fine to talk and rabble-rouse about longevity, but we felt such efforts would be much more effective if they were paired with a clear and consistent call to action – a path to walk the walk, so to speak. As this idea coalesced we formed the nonprofit LEAF to support this initiative, and the rest is history. Not every one from the initial discussions in 2012 remained throughout the intervening years, but we are thankful to all who gave us ideas in those early days of the movement.

I’d like to hear your take on why we have to advocate and raise funds at all – why the whole world isn’t rising up in support of treatments for the causes of aging.

The reasons why people and society at large have not prioritized anti-aging research thus far are myriad: fear of radical change, a history of failed attempts making it seem like a fools errand, long timescales making it a difficult issue for election-focused politicians to support, etc. The reason I find most personally interesting relates to cognitive bias – specifically the fact that our built-in mental hardware is ill-equipped to handle questions like “do you want to live 100 more years?” If instead you ask the questions “Do you want to be alive tomorrow?” and “Given that your health and that of your loved ones remains the same, do you suspect your answer to the first question will change tomorrow?”, the answers tend to be more positive.

This leads me to conclude that the state of affairs is not necessarily as depressing for our cause as it might appear, and that reframing the issue of healthy life extension in a way that will inspire and unite the broader populace is possible. Aubrey de Grey has spoken about “Longevity Escape Velocity” in relation to the bootstrapping of biomedical research, but I think the same idea applies to the public perception of life extension as well. The sooner we can galvanize the public to support therapies that yield positive results the easier it will become to invite others to join in this great work. It is all about jump starting the positive feedback loop, and that is why we believe rallying the crowd behind critical research and trumpeting these successes publicly is so vitally important.

What the future plans for Lifespan.io and the Life Extension Advocacy Foundation?

In addition to scaling up our ability to run successful campaigns on Lifespan.io, we look forward to improving our infrastructure at LEAF by bringing on some staff members to join the team. LEAF has largely been a volunteer effort thus far, and having the support of a staff will allow us to take on more campaigns as well as further improve the workflow to create and promote them. This will also free me up personally to more actively pursue potential grand slams for the movement, such as collaborations with prominent YouTube science channels to engage the public and policy related goals like the inclusion of a more useful classification of aging in the ICD-11.

Do you have any favored areas in research at the moment? Is there any particular field for which you’d like to see researchers approaching you for collaboration?

Senolytics is certainly an exciting area of research right now (congratulations Major Mouse Testing Program!), and a combination of successful senolytics with stem cell therapies could be a potential game changer. That being said I’d also like to see projects which address the truly core mechanics of aging, such as how damage is aggregated during stem cell division, and the potential differences in this process between somatic and germ cells. How can the germ line renew itself for essentially infinity? The real mystery here is not that we grow old, but how we are born young.

A related question: where do you see aging and longevity research going over the next few years?

In the near future we will likely continue to see the pursuit of compounds which restore bodily systems failing with age to a more youthful state. This will include validating in higher organisms molecules that have shown this sort of promise: rapamycin, metformin, IL-33 for Alzheimer’s, etc. This approach may sound incremental, but it actually signals a great paradigm shift from the old system of mostly ineffective “preventative measures” such as antioxidants. Things like nicotinamide mononucleotide (NMN), IL-33 – if successful these types of therapies can be applied when you are old, and help restore your bodily systems to youthful levels. That would be a pretty big deal.

Funding is ever the battle in the sciences, and especially for aging. Obviously you have strong opinions on this topic. How can we change this situation for the better?

I believe the key to greater funding, both from public and private sources, is to build up an authentic and powerful grassroots movement in support of healthy life extension. Not only can such a movement raise funds directly, but it also communicates to businesses and governments that this is an issue worth supporting. An instructive example to look at here is the work of Mary Lasker and Sydney Farber to bring about the “War on Cancer”. Through galvanizing the public with efforts such as the “Jimmy Fund”, they effected social and political change on the issue, and helped turn cancer from a pariah disease into a national priority. If we all work together to build an inclusive and action-orientated movement, we can do the same.

Reason is the founder of The Longevity Meme (now Fight Aging!). He saw the need for The Longevity Meme in late 2000, after spending a number of years searching for the most useful contribution he could make to the future of healthy life extension. When not advancing the Longevity Meme or Fight Aging!, Reason works as a technologist in a variety of industries.
This work is reproduced here in accord with a Creative Commons Attribution license. It was originally published on FightAging.org.



25% Median Life Extension in Mice via Senescent Cell Clearance, Unity Biotechnology Founded to Develop Therapies – Article by Reason

No comments yet

Categories: Science, Transhumanism, Tags: , , , , , , , , , ,

The New Renaissance HatReason

With today’s news, it certainly seems that senescent cell clearance has come of age as an approach to treating aging and age-related conditions. Some of the leading folk in the cellular senescence research community today published the results from a very encouraging life span study, extending life in mice via a method of removing senescent cells. This is much the same approach employed in one of the first tests of senescent cell clearance, carried out in accelerated aging mice a few years ago, but in this case normal mice were used, leaving no room to doubt the relevance of the results. The researchers have founded a new company, Unity Biotechnology, to develop therapies for the clinic based on this technology. Clearance of senescent cells has been advocated as a part of the SENS vision for the medical control of aging for more than a decade now, and it is very encouraging to see the research and development community at last coming round to this view and making tangible progress.

Senescent cells have removed themselves from the cycle of replication in reaction to cell and tissue damage, or a local tissue environment that seems likely to result in cancer. Their numbers accumulate with age. Most are destroyed by the immune system or their own programmed cell death mechanisms, but enough linger for the long term for their growing presence to be one of the contributing causes of the aging process. These cells behave badly, secreting harmful signals that degrade tissue function, generate inflammation, and alter the behavior of surrounding cells as well. Near every common age-related condition is accelerated and made worse by the presence of large numbers of senescent cells. We would be better off without them, aging would be slowed by the regular removal of these errant cells, and the therapies to make that possible are on the near horizon.

The mouse lifespan study is the important news here, as it demonstrates meaningful extension of median life span through removal of senescent cells, the first such study carried out in normal mice for this SENS-style rejuvenation technology. This sort of very direct and easily understood result has a way of waking up far more of the public than the other very convincing evidence of past years. So it looks like Oisin Biotechnology, seed funded last year by the Methuselah Foundation and SENS Research Foundation to bring a senescent cell clearance therapy to market, now has earnest competition. Insofar as the competitive urge in business and biotechnology speeds progress and produces better results, let the games begin, I say.

Scientists Can Now Radically Expand the Lifespan of Mice – and Humans May Be Next


Researchers have made this decade’s biggest breakthrough in understanding the complex world of physical aging. The researchers found that systematically removing a category of living, stagnant cells (ones which can no longer reproduce) extends the lives of otherwise normal mice by 25 percent. Better yet, scouring these cells actually pushed back the process of aging, slowing the onset of various age-related illnesses like cataracts, heart and kidney deterioration, and even tumor formation. “It’s not just that we’re making these mice live longer; they’re actually stay healthier longer too. That’s important, because if you were going to equate this to people, well, you don’t want to just extend the years of life that people are miserable or hospitalized.” By rewriting a tiny portion of the mouse genetic code, the team developed a genetic line of mice with cells that could, under the right circumstances, produce a powerful protein called caspase when they start secreting p16. Caspase acts essentially as a self-destruct button; when it’s manufactured in a cell, that cell rapidly dies. So what exactly are these circumstances where the p16 secreting cells start to create caspase and self-destruct? Well, only in the presence of a specific medicine the scientists could give the mice. With their highly-specific genetic tweak, the scientists had created a drug-initiated killswitch for senescent cells. In today’s paper, the team reported what happened when the researchers turned on that killswitch in middle-aged mice, effectively scrubbing clean the mice of senescent cells.

Naturally occurring p16Ink4a-positive cells shorten healthy lifespan


Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16Ink4a-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16Ink4a-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.

Unity Biotechnology Launches with a Focus on Preventing and Reversing Diseases of Aging


Unity will initially focus on cellular senescence, a biological mechanism theorized to be a key driver of many age-related diseases, including osteoarthritis, glaucoma and atherosclerosis. “Imagine drugs that could prevent, maybe even cure, arthritis or heart disease or loss of eyesight. It’s an incredible aspiration. If we can translate this biology into medicines, our children might grow up in significantly better health as they age. There will be many obstacles to overcome, but our team is committed and inspired to achieve our mission. This has been a long journey, and we’re at the point now where we can start making medicines to achieve in humans what we’ve achieved in mice. I can’t wait to see what happens as we move into the clinic.”

To close this post, and once again, I think it well worth remembering that SENS rejuvenation biotechnology advocates and supporters have been calling for exactly this approach to treating aging for more than a decade. That call was made based on the evidence arising from many fields of medical research, and from a considered perspective of aging as a process of damage accumulation, one that can be most effectively treated by repair of that damage. The presence of senescent cells is a form of damage. SENS was not so long ago derided and considered out on the fringe for putting forward that position, but for several years now it has been very clear that the SENS viewpoint was right all along. I strongly encourage anyone who remains on the fence about the validity of the SENS proposals for the treatment of aging to reexamine his or her position on the science.

Reason is the founder of The Longevity Meme (now Fight Aging!). He saw the need for The Longevity Meme in late 2000, after spending a number of years searching for the most useful contribution he could make to the future of healthy life extension. When not advancing the Longevity Meme or Fight Aging!, Reason works as a technologist in a variety of industries.
This work is reproduced here in accord with a Creative Commons Attribution license. It was originally published on FightAging.org.


Zero-Gravity Orbital Habitation Causes Changes That Are at Least Superficially Similar to Accelerated Aging – Article by Reason

No comments yet

Categories: Technology, Transhumanism, Tags: , , , , , , , , , , , ,

The New Renaissance HatReason

That old people will go into orbit to escape the rigors of gravity and thus live longer in their declining years was a staple of golden age and later science fiction. These works were written at a time in which our knowledge of human biochemistry – and the application of that knowledge to medicine – was crude in comparison to today. It is fascinating that we can say that for such a short span of years, a mere short lifetime past, but the differences between the medicine of the 1950s and the medicine of today are profound indeed. The writers of that time largely envisaged a future incorporating great gains in energy generation, and a consequent diaspora from Earth, while computation, medicine and the human condition remained much unchanged; older spacemen in the outer reaches struggling with heart disease in their fifties. Instead we found that expanding the generation, storage, transmission, and application of energy is very hard, and the largely unanticipated information revolution occurred instead. We lost the near future of cheap heavy lift to orbit and the solar system at our beck and call, but gained Moore’s Law, biotechnology, nanotechnology, a pervasive internet, and medical progress that is in the early stages of conquering heart disease and may yet save us from all of degenerative aging.

As it turns out, retreating from the rigors of gravity may well have the opposite effect to that imagined by the authors of the last century. Among the alterations produced by orbital habitation in zero gravity are those that appear, at least superficially, much like accelerated aging of the cardiovascular system. The root causes have yet to be pinned down, since very few people are actually researching this topic, but since the onset of these symptoms is fairly rapid, I’d guess at the cause being more a matter of regulatory dysfunction than increased tissue damage, such as the presence of cross-links related to arterial stiffening in aging. Here I’ll point out a few links to the work of one research group on this topic in recent years:

Waterloo to lead new experiment aboard International Space Station


The experiment will link changes in astronauts’ hearts and blood vessels with specific molecules in the blood to determine why astronauts experience conditions that mimic aging-related problems and chronic diseases on earth. The findings will help identify important indicators for chronic disease and assist with the development of early interventions for people on earth. “We know that astronauts return from space with stiffer arteries and resistance to insulin, conditions affecting many adults as they age. For the first time, we will be able to track exactly how – and why – the body’s blood vessels change, and use these findings to potentially improve quality of life and the burden of chronic disease.” “In space, astronauts’ bodies show aging-like changes much faster than on Earth. The International Space Station provides a unique platform to study aging-related conditions providing insights that can be used to help understand some of the biggest health issues affecting society. Our research to date suggests that even though astronauts exercise every day, the actual physical demands of tasks of daily living are greatly reduced due to the lack of gravity. This lifestyle seems to cause changes in the vascular system and in the body’s ability to regulate blood glucose that would normally take years to develop on earth.”

U.Waterloo – Vascular Aging and Space Research Program


We study factors related to cardiovascular health with aging. One focus is on blood pressure regulation and its impact on brain blood flow to help us understand some of the factors that could contribute to falls in the elderly, especially those that occur on rising from bed. Another focus is on aging blood vessels. We have reported a strong link between peripheral arterial stiffness and a reduction in brain blood flow. Our space research program is very active. We recently completed the study Cardiovascular and Cerebrovascular Control on Return from the International Space Station (CCISS). We are currently collecting data for the project Cardiovascular Health Consequences of Long-Duration Space Flight (Vascular).

Cardiovascular Health Consequences of Long-Duration Space Flight (Vascular)


Cardiovascular Health Consequences of Long-Duration Space Flight (Vascular) investigates the impact of long-duration space flight on the blood vessels of astronauts. Space flight accelerates the aging process, and it is important to understand this process to develop specific countermeasures. Data is collected before, during, and after space flight to assess inflammation of the artery walls, changes in blood vessel properties, and cardiovascular fitness. Spaceflight can cause stiffening of the arteries, affecting the body’s ability to control blood pressure. This investigation assessed the blood vessels of astronauts and found decreased flexibility of the carotid artery during flight. Researchers found no relationship between the level of physical fitness and this decrease. The experiment also provided data on the mechanisms behind increased arterial stiffness from spaceflight. Further research is needed to establish effective ways to counter the cardiovascular consequences of spaceflight and ultimately help treat increased arterial stiffness from aging on Earth, which can cause high blood pressure and organ damage.

Impaired cerebrovascular autoregulation and reduced CO2 reactivity after long duration spaceflight


Long duration habitation on the International Space Station (ISS) is associated with chronic elevations in arterial blood pressure in the brain compared with normal upright posture on Earth and elevated inspired carbon dioxide. Although results from short-duration spaceflights suggested possibly improved cerebrovascular autoregulation, animal models provided evidence of structural and functional changes in cerebral vessels that might negatively impact autoregulation with longer periods in microgravity. Seven astronauts (1 woman) spent 147 ± 49 days on ISS. Preflight testing (30-60 days before launch) was compared with postflight testing on landing day or the morning 1 or 2 days after return to Earth. The results indicate that long duration missions on the ISS impaired dynamic cerebrovascular autoregulation and reduced cerebrovascular carbon dioxide reactivity.

Recent findings in cardiovascular physiology with space travel


The cardiovascular system undergoes major changes in stress with space flight primarily related to the elimination of the head-to-foot gravitational force. A major observation has been that the central venous pressure is not elevated early in space flight yet stroke volume is increased at least early in flight. Recent observations demonstrate that heart rate remains lower during the normal daily activities of space flight compared to Earth-based conditions. Structural and functional adaptations occur in the vascular system that could result in impaired response with demands of physical exertion and return to Earth. Cardiac muscle mass is reduced after flight and contractile function may be altered. Regular and specific countermeasures are essential to maintain cardiovascular health during long-duration space flight.

Reason is the founder of The Longevity Meme (now Fight Aging!). He saw the need for The Longevity Meme in late 2000, after spending a number of years searching for the most useful contribution he could make to the future of healthy life extension. When not advancing the Longevity Meme or Fight Aging!, Reason works as a technologist in a variety of industries.
This work is reproduced here in accord with a Creative Commons Attribution license. It was originally published on FightAging.org.


On Viewing 2001: The First Transhumanist Film – Article by Edward Hudgins

No comments yet

Categories: Culture, Technology, Transhumanism, Tags: , , , , , , , ,

The New Renaissance HatEdward Hudgins
November 20, 2015

I recently saw 2001: A Space Odyssey again on the big screen. That’s the best way to see this visually stunning cinematic poem, like I saw it during its premiere run in 1968. The film’s star, Keir Dullea, attended that recent screening and afterward offered thoughts on director Stanley Kubrick’s awe-inspiring opus.


He and many others have discussed the visions offered in the film. Some have come to pass: video phone calls and iPad tablets, for example. Others, sadly, haven’t: regularly scheduled commercial flights to orbiting space stations and Moon bases.

But what should engage our attention is that the film’s enigmatic central theme of transformation is itself transforming from science fiction to science fact.

From apes to man

The film’s story came from a collaboration between Kubrick and sci-fi great Arthur C. Clarke. If you’re familiar with Clarke’s pre-2001 novel Childhood’s End and his short story “The Sentinel” you’ll recognize themes in the film.

In the film we see a pre-human species on the brink of starvation, struggling to survive. An alien monolith appears and implants in the brain of one of the more curious man-apes, Moonwatcher, an idea. He picks up a bone and bashes in the skull of one of a herd of pigs roaming the landscape. Now he and his tribe will have all the food they need.

We know from Clarke’s novel, written in conjunction with the film script, that the aliens actually alter Moonwatcher’s brain, giving it the capacity for imagination and implanting a vision of him and his tribe filled with food. He sees that there is an alternative to starvation and acts accordingly. The aliens had juiced evolution. Kubrick gives us the famous scene where Moonwatcher throws the bone in the air. As it falls the scene cuts ahead to vehicle drifting through space. Natural evolution over four million years has now transformed ape-men into modern technological humans.

From stars to starchild

In the film, astronauts discover a monolith buried on the Moon, which sends a signal toward Jupiter. A spaceship is sent to investigate, and astronaut Dave Bowman, played by Dullea, discovers a giant monolith in orbit. He enters it and passes through an incredible hyperspacial stargate. At the end of his journey, Bowman is transformed by the unseen aliens’ monolith into a new, higher life form, an embryo-appearing starchild with, we presume, knowledge and powers beyond anything dreamt of by humans. He is transhuman!


Kubrick and Clarke are making obvious references to Nietzsche’s Also Sprach Zarathustra. In that book Nietzsche offers a vision of a human going through three transformations, ending up as a child. “Innocent is the child . . . a new beginning . . . a first movement . . . a holy ‘Yes’.” The child is the creator and the potential for the creation of new values. And, of course, Kubrick used the introduction/sunrise music from the Richard Strauss tone poem named for Nietzsche’s work in the film’s famous opening; in the scene when an idea dawns in the brain of the ape-man; and at the end, when the human is reborn as the starchild. This is as over-the-top symbolism as there ever was!

From evolution to creation

In 2001 natural evolution and alien intervention transform ape-man, to man, to übermensch. Today, we humans are taking control of our own evolution and are beginning to transform ourselves—but into what?

Futurists like Max and Natasha Vita More and Ray Kurzweil have given us the transhumanist philosophy, the idea that we humans can and should use technology to overcome our biological limits, enhancing our physical and mental capacities. Scientists, researchers, and engineers today are doing just this.

They are creating advanced bionic implants and prosthetics to replace lost limbs or body parts. They are working on brain-machine interfaces that could better merge the two. They are experimenting with actually implanting information into brains. They have genetically engineered certain cells to attack only cancer cells. They are working to program nanobots to do the same. And they are understanding the deep mechanisms that cause cells over time to break down, and are exploring ways to “turn off” this process—that is, to actually stop aging. Could we engineer superbrains for real, eternally young übermenschen in decades to come?

Today, the fundamental theme of 2001, human transcendence, is being made real by we humans rather than by alien monoliths. So when you next see this classic film, you might see still see the starchild as a piece of evocative fiction. But you can appreciate that we humans are putting ourselves on a path to something in the future beyond anything dreamt of by humans.

Dr. Edward Hudgins directs advocacy and is a senior scholar for The Atlas Society, the center for Objectivism in Washington, D.C.

Copyright The Atlas Society. For more information, please visit www.atlassociety.org.


Lifespan Challenge: Support the MitoSENS Mitochondrial Repair Project Research Fundraiser – Video by G. Stolyarov II

No comments yet

Categories: Announcements, Science, Transhumanism, Tags: , , , , , , , , , , , , ,

The New Renaissance HatG. Stolyarov II
October 21, 2015

Mr. Stolyarov, author of “Death is Wrong” and Chief Executive of the Nevada Transhumanist Party (NTP), challenges all members of the NTP and the general public to donate to life-extension research – particularly, the ongoing MitoSENS Mitochondrial Repair Project for which crowdfunding is currently being conducted on Lifespan.io.



MitoSENS Mitochondrial Repair Project Description
Updates and Stretch Goals for the MitoSENS Mitochondrial Repair Project
SENS Research Foundation
– “The #LifespanChallenge Starting on October 1 – International Longevity Day” – Article by Keith Comito
Death is Wrong – Official Home Page
Nevada Transhumanist Party – Constitution and Bylaws
Nevada Transhumanist Party – Facebook Page


Achieving a Bright Future: Opportunities and Obstacles – G. Stolyarov II Interviews Demian Zivkovic

No comments yet

Categories: Philosophy, Politics, Technology, Transhumanism, Tags: , , , , , , , , , , , , , , , ,

 The New Renaissance Hat
G. Stolyarov II and Demian Zivkovic
January 19, 2015

Mr. Stolyarov invites Demian Zivkovic to discuss visions of the future and humankind’s prospects for achieving a bright future in time for us to experience and enjoy it. The discussion focuses on the following questions:

(1) What do you consider to be humankind’s best opportunities for achieving a bright future within the next several decades?
(2) What do you consider to be the greatest obstacles to the realization of such a bright future?
(3) How could such obstacles be overcome?

About Demian Zivkovic

Demian Zivkovic, 23 years old, is a student of artificial intelligence and philosophy, and founder and president of the Arma’thwynn Society – an international transhumanist think tank comprised of a group of transhumanism-oriented professionals, students, and entrepreneurs interested in the interdisciplinary approach to advancing transhumanist technologies. Demian has been involved in several endeavors, including interviewing Professor Aubrey de Grey, organizing a transhumanism lecture in The Netherlands now, and spreading Death is Wrong – Mr. Stolyarov’s illustrated children’s book on indefinite life extension – in The Netherlands.

1 2 3